Biogen(BIIB) Stock Price Today | Quotes & News

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US Stock MarketDetailed Quotes

BIIB Biogen

Watchlist

136.840
-1.530-1.11%

Close Mar 31 16:00 ET

136.840
0.0000.00%

Post 20:01 ET

20.03BMarket Cap12.24P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

William Blair Maintains Biogen(BIIB.US) With Buy Rating
Moomoo NewsMar 28 20:31 ET · Ratings
European Drug Regulator Gives Thumbs Down To Eli Lilly's Alzheimer's Drug, Analyst Says It Is Incremental Win For Biogen
BenzingaMar 28 15:34 ET
Biogen's Favorable Outlook: Navigating Regulatory Challenges and Safety Advantages Justify Buy Rating
TipRanksMar 28 10:15 ET · Ratings
Eli Lilly Fails to Win EU Backing for Alzheimer's Therapy
Seeking AlphaMar 28 07:48 ET
RFK Jr. Reportedly Plans 10,000 Job Cuts in HHS With FDA, CDC, Medicare Affected
Seeking AlphaMar 27 08:22 ET
Hospital Stocks Are Ready to Rebound, Deutsche Bank Says
BNN BloombergMar 25 13:51 ET

Comments

Teddy123

Mar 24 19:34

Biogen Announces Plans for New Global Headquarters and Innovation Hub in Kendall Square

$Biogen (BIIB.US)$
Biogen's Bold Move: 580,000 sq ft Innovation Powerhouse to Transform Kendall Square Research Hub

Teddy123

Mar 11 19:35

Biogen Initiates Phase 3 Study of Felzartamab for the Treatment of Late Antibody-Mediated Rejection (AMR) in Kidney Transplant Patients

$Biogen (BIIB.US)$
Biogen's Breakthrough Drug Enters Final Testing Phase for Critical Kidney Transplant Complication

ColdJoke

Mar 7 23:56

confirmed bottom

$Biogen (BIIB.US)$ confirmed technical bottom

thoughtful Bat_8163

Feb 12 22:41

$Biogen (BIIB.US)$ Leqembi sale 81 m, last quarter was 51 m. more than 50% higher. Third quarter (51m) was 30% higher than the second. Even though it is just a small percentage of the total revenue (2.46 billion), the sale of Leqembinis is accelerating

Moomoo News Global

Feb 5 21:04

Columns Tariff Investment Opportunities: Four Sectors as Potential Safe Havens

Over the weekend, President Donald Trump announced tariffs on the U.S.'s top three trading partners—Canada, Mexico, and China—and threatened similar measures against the EU. On Monday, U.S. stocks experienced a selloff, with the major indices dropping. Losses narrowed, however, after news broke of a delay in imposing tariffs on Mexico.
Market worries over the tariffs focus on two key issues. U.S. companies that depend heavily ...

BIIB Biogen

Trade Overview

Capital Trend

News

Comments

Market Insights